Stay updated with breaking news from Endocrine Disorders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hosts break down the FLOW trial, take a deep dive into secondary findings, and provide insight into how this alters the perception of the role for semaglutide in management of CKD in type 2 diabetes.
A recent decision by the Centers for Medicare & Medicaid Services to cover popular new weight loss drugs that provide additional health benefits could be a “game changer” for potentially thousands of obese nursing home patients struggling with comorbidities.
A surprising thing is happening to some women on weight-loss drugs who’ve struggled with fertility issues: They’re getting pregnant. That’s leading to questions about the safety of medications from Novo
In this episode, all things AID from the 17th annual ATTD, including updates from Insulet Corporation and Omnipod, study data from the Control IQ algorithm, the SMASH study, and a peak into the future with the Neural Network AID algorithm.
In this peisode, hosts disucss top news and updates in automated insulin delivery from ATTD 2024, with a focus on new data from the T1D Exchange and a read-out from the CRISTAL study.